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Summary
Background.  —  Data  supporting  epidemiological  transition  from  a  predominant  burden  of  infec-
tious diseases  to  one  of  chronic  diseases  in  Africa  result  mostly  from  hospital  surveys.
Aim. —  To  estimate  the  cardiovascular  disease  (CVD)  burden  in  Gabon.Epidemiology; Methods.  —  The  study  was  conducted  in  Ntoum  (8765  inhabitants).  All  subjects  aged  greater
invited  to  participate.  Participants  were  interviewed  about  CVDHypertension or equal  to  40  years  were  history and  risk  factors;  they  responded  to  questionnaires  on  claudication  and  angina  and
had a  clinical  examination,  including  lower  limb  pulse  palpation  and  bilateral  brachial
pressure  measurement.  Subjects  were  considered  to  have  CVD  in  case  of  history  of  CVD
Abbreviations: BMI, body mass index; CAD, coronary artery disease; CI, conﬁdence interval; CVD, cardiovascular disease; DM, diabetes
mellitus; ECQ, Edinburgh Claudication Questionnaire; HR, hazard ratio; PAD, peripheral artery disease; WHO, World Health Organization.
∗ Corresponding author. Fax: +33 5 55 05 63 84.
E-mail address: philippe.lacroix@unilim.fr (P. Lacroix).
1875-2136/$ — see front matter © 2012 Elsevier Masson SAS. All rights reserved.
doi:10.1016/j.acvd.2011.12.005
78  E.B.  Ngoungou  et  al.
(coronary  artery,  cerebrovascular  and  peripheral  arterial  diseases),  a  positive  questionnaire  or
an abnormal  ﬁnding  during  clinical  examination.
Results.  —  The  study  included  736  subjects  (313  men;  423  women).  Systolic  hypertension  was
highly prevalent  (up  to  47.7%  and  53.7%  in  men  and  women  aged  50  to  60  years,  respectively).  Of
the 382  patients  with  hypertension,  74  (19.4%)  were  treated  and  only  22  (5.8%)  were  considered
to have  controlled  hypertension.  Overall,  CVD  was  identiﬁed  in  98  (13.3%)  cases.  Overall  and
newly diagnosed  CVD  prevalence  rates  were  14.7%  and  11.5%  for  men  and  14.9%  and  8.9%  for
women, respectively.  The  presence  of  CVD  was  associated  with  hypertension  (hazard  ratio  [HR]
3.69, 95%  conﬁdence  interval  [CI]  2.21—6.16;  P  <  0.0001).  Hypertension  was  predictive  of  stroke
(HR 4.57,  95%  CI  1.26—16.50;  P  <  0.05),  peripheral  artery  disease  (HR  2.03,  95%  CI  1.03—4.00;
P <  0.05)  and  subclavian  artery  stenosis  (HR  5.79,  95%  CI  2.21—15.2;  P  <  0.05).
Conclusions.  —  Our  ﬁndings  provide  strong  evidence  of  ongoing  epidemiological  transition  in
Gabon, where  CVD  prevalence  rates  increase  mainly  with  hypertension,  affecting  about  one  in
six individuals  aged  over  40  years.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
But.  —  L’objectif  de  cette  étude  est  de  préciser  la  prévalence  des  affections  cardiovasculaires
symptomatiques  et  asymptomatiques  en  population  générale  au  Gabon.
Méthodes.  —  L’enquête,  effectuée  dans  la  région  de  Ntoum  (8765  habitants),  a  inclus  tous  les
sujets supérieurs  ou  égaux  à  40  ans  ;  elle  comportait  la  recherche  des  antécédents  et  facteurs
de risque  cardiovasculaire,  l’administration  de  questionnaires  pour  l’angor  et  la  claudication,
un examen  clinique  avec  une  prise  de  pression  artérielle  aux  deux  bras  et  la  palpation  des
pouls des  membres  inférieurs.  Les  sujets  ont  été  considérés  comme  présentant  une  affection
cardiovasculaire  en  cas  d’antécédent  de  coronaropathie,  cérébrovasculaire,  d’artériopathie  des
membres inférieurs,  devant  un  questionnaire  positif  ou  d’anomalie  lors  de  l’examen  clinique.
Résultats.  — La  population  était  de  736  sujets  (313  hommes,  423  femmes).  La  prévalence  de
l’hypertension  artérielle  était  élevée  (entre  50  à  60  ans,  47,7  %  pour  les  hommes  et  53,7  %
pour les  femmes).  Parmi  les  382  patients  hypertendus,  74  (19,4  %)  étaient  traités  et  22  (5,8  %)
controlés.  La  prévalence  d’une  affection  cardiovasculaire  était  de  13,3  %  (98  sujets)  ;  pour  les
hommes et  les  femmes,  elle  s’élevait  respectivement  à  14,7  %  et  11,5  %,  et  à  11,5  %  et  8,9  %
pour les  nouvellement  identiﬁées.  L’hypertension  augmentait  le  risque  général  (HR  3,69,  IC
95 %  2,21—6,16  ;  p  <  0,001),  celui  d’accident  vasculaire  cérébral  (HR  4,57,  IC  95  %  1,26—16,50  ;
p <  0,05),  d’artériopathie  des  membres  (HR  2,03,  IC  95  %  1,03—4,00  ;  p  <  0,05)  et  de  sténose
subclavière  (HR  5,79,  IC  95  %  2,21—15,2  ;  p  <  0,05).
Conclusions.  — Ces  données  suggèrent  une  transition  épidémiologique  au  Gabon.  L’hypertension
semble un  important  problème  de  santé  publique  dans  ce  pays.
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ackground
or  a  very  long  period,  cardiovascular  diseases  (CVD)
ere  considered  as  negligible  in  African  countries,  espe-
ially  compared  with  other  public  health  issues.  Recent
ata  demonstrated  an  epidemiological  transition  from  a
redominant  burden  of  infectious  diseases  to  one  with
hronic  diseases,  particularly  CVD  related  to  atheroscle-
osis.  The  rate  of  CVD  mortality  is  increasing  in  regions
f  sub-Saharan  African  [1—3]. Nowadays,  cardiovascular
eaths  are  by  far  more  frequent  in  developing  countries
han  in  developed  countries  [4].  This  situation  might  result
rom  a  complex  combination  of  population,  lifestyle  and
enetic  characteristics.  Increased  life  expectancy  is  also
sually  associated  with  an  increased  burden  of  degenerative
isorders.In  sub-Saharan  Africa,  most  data  result  from  hospital
urveys.  The  INTERHEART  study  in  Africa  [5]  demonstrated
dentical  relationships  between  common  risk  factors  and
i
r
2s  droits  réservés.
cute  myocardial  infarction  in  African  populations  and  the
lobal  population.  There  is  growing  evidence  of  increasing
ates  of  CVD  mortality  in  African  countries  [2,3], although
he  rates  are  still  lower  than  in  more  developed  countries.
Conversely,  few  population-driven  studies  are  conducted
n  Africa.  Most  population  surveys  were  conducted  in  South
frica  [6—8]: the  prevalence  of  CVD  risk  factors  in  the  rural
ommunity  of  Limpopo  was  reported  as  high,  close  to  the
revalence  described  in  the  western  population  [6].  The
revalence  of  hypertension  in  sub-Saharan  African  popula-
ions  was  generally  low,  but  major  changes  have  occurred
ecently,  with  an  increasing  incidence  not  only  in  urban
opulations  but  also  extending  into  rural  populations  [9].
he  prevalence  of  stroke  was  documented  as  being  up  to
00/100,000  inhabitants  of  the  Agincourt  area  in  South
frica  [7].  Data  from  Sowetto  supported  the  emergence  of
schaemic  heart  disease  in  the  urban  population  [8].  Periphe-
al  artery  disease  (PAD)  prevalence  rates  were  estimated  at
9.3%  in  the  Cape  Town  population  aged  greater  than  50
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CCVD  in  Gabon  
years  and  more  than  25%  in  the  Agincourt  population  aged
greater  than  60  years.  Data  regarding  the  burden  of  CVD
and  CVD  risk  factors  in  other  African  countries  are  scarce.
Most  of  these  countries  have  limited  resources  and  primary
prevention  is  consequently  of  outmost  importance.  There-
fore,  knowledge  about  the  epidemiology  of  CVD  and  the  use
of  simple  methods  to  detect  subclinical  CVD  are  useful  for
appropriate  preventive  strategies.
The  aim  of  this  study  was  to  identify  the  prevalence  of
CVD  and  associated  risk  factors  in  Gabon,  a  sub-Saharan
country  on  the  east  coast  of  Africa.
Methods
Data collection and deﬁnition
The  study  is  ancillary  to  a  survey  regarding  the  prevalence  of
epilepsy  [10]  in  the  community  of  Ntoum,  Gabon.  Ntoum  is
a  city  with  8765  inhabitants,  in  the  administrative  region  of
the  estuary,  located  in  northeast  Gabon.  The  population  is
mainly  rural  but  also  includes  business  and  industry  workers.
Overall,  6259  subjects  were  included  in  the  ﬁrst  survey  and
736  in  the  ancillary  study;  subjects  aged  greater  or  equal
to  40  years  were  included  in  the  ancillary  study.  In  the  last
census,  subjects  aged  more  than  40  years  represented  14%
of  the  Gabonese  population  [11].
Over  a  period  of  12  days,  a  group  of  46  ﬁeld  investigators
visited  all  of  the  households  in  the  area.  A  group  of  10  guides
accompanied  the  investigators.  Each  day,  the  investigators
visited  a  district  that  had  been  previously  determined;  all
of  the  residents  had  already  been  informed  about  the  study.
The  investigators  were  trained  by  one  of  the  authors  (EN).
All  subjects  aged  more  than  40  years  were  also  asked  to
participate  in  the  CVD  survey;  all  participants  gave  their
informed  consent.  Subjects  were  interviewed  about  their
smoking  status  (non-smokers  or  ever  smokers,  including
former  or  current  smokers)  and  history  of  diabetes  melli-
tus  (DM),  hypertension  and  dyslipidaemia.  Health  records
and  prescriptions  were  analysed.  Participants  reporting  DM
were  asked  about  their  use  of  insulin  and  oral  medications.
Participants  reporting  any  use  of  lipid-lowering  medication
or  anti-DM  drugs  were  considered  as  dyslipidaemic  or  dia-
betic,  respectively.  The  subjects  were  also  asked  about  their
history  of  documented  stroke,  heart  or  vascular  disorders.
Height  and  weight  were  measured  with  the  participants
being  barefoot  and  wearing  light  clothing.  Body  mass  index
(BMI)  was  calculated  as  kg/m2.  A  waist  measurement  was
performed  using  a  non-stretching  tape  with  the  subject  in
the  standing  position.  Blood  pressure  was  measured  on  both
arms  with  a  mercury  manometer.  Hypertension  was  deﬁned
either  as  the  use  of  antihypertensive  drugs  or  as  resting  arm
systolic  blood  pressure  greater  or  equal  to  160  mmHg  (par-
ticipant  sitting  for  5  minutes).  Lower  limb  peripheral  pulses
(posterior  tibial  and  dorsalis  pedis)  were  palpated  in  the
same  position.  As  the  population  is  French  speaking,  French
versions  of  the  World  Health  Organization  (WHO)  Rose  angina
questionnaire  and  the  Edinburgh  claudication  questionnaire
(ECQ)  for  intermittent  claudication  were  used  [12,13].
Coronary  artery  disease  (CAD)  was  deﬁned  as  a  history
of  CAD  reported  by  the  participant  or  a  positive  WHO  Rose
angina  questionnaire.  Cerebrovascular  disease  was  deﬁned
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s  a  report  of  a  documented  stroke  or  transient  ischaemic
ttack.  PAD  was  deﬁned  as  a  documented  history  of  PAD,  an
bsent  posterior  tibial  pulse  or  a  ‘positive’  or  ‘possible’  ECQ
‘possible’  being  deﬁned  as  calf  pain  on  walking  but  other-
ise  not  fully  concordant  with  the  ECQ  criteria)  [14]. Finally,
n  interarm  systolic  blood  pressure  difference  greater  than
5  mmHg  deﬁned  the  presence  of  subclavian  stenosis,  a
ondition  recently  found  to  be  a  marker  of  poorer  CVD
rognosis  [15]. The  participants  were  considered  as  having
VD  in  case  of  any  of  the  above-mentioned  situations.  In  the
bsence  of  a  speciﬁc  ethical  committee  in  this  country,  the
urvey  was  approved  by  the  Ministry  of  Public  Health  and  of
abon.
tatistical methods
ata  are  reported  as  mean  ±  standard  deviation.  Categori-
al  data  are  presented  as  percentages  with  95%  conﬁdence
ntervals  (CIs)  when  appropriate.  Comparisons  within  groups
ere  made  using  the  Chi2 test  for  categorical  variables  and
tudent’s  t  test  for  continuous  variables.  To  assess  the  asso-
iation  between  CVD  and  the  risk  factors,  a  multiple  logistic
egression  analysis  was  used  to  determine  the  independent
redictive  factors,  using  a  backward  stepwise  method.  A  P
alue  <  0.05  was  ﬁxed  for  statistical  signiﬁcance.  Statistical
nalyses  were  performed  using  Statview  5.0  software  (SAS
nstitute,  Cary,  NC,  USA).
esults
 total  of  736  subjects  (313  men;  423  women)  were  included
n  this  survey.  Table  1  presents  the  main  characteristics  of
he  population.  Smoking  was  more  prevalent  among  men,
hile  BMI  was  higher  in  women.  Hypertension  was  highly
revalent:  up  to  47.7%  and  53.7%  in  men  and  women  aged
0  to  60  years,  respectively  (Fig.  1).  Among  the  382  partici-
ants  with  hypertension,  74  (19.4%)  were  treated  and  only
2  (5.8%)  had  controlled  blood  pressure.
Among  the  736  participants,  98  (13.3%)  were  identiﬁed
s  having  a  CVD.  The  prevalences  of  overall  and  newly  diag-
osed  CVD  were  14.7%  and  11.5%  for  men  and  14.9%  and
.9%  for  women,  respectively  (Fig.  2).  The  distribution  of
ifferent  abnormal  conditions  is  presented  in  Table  2.  CVD
revalences  according  sex  and  age  are  displayed  in  Fig.  3.
ypertension  was  more  prevalent  in  the  case  of  CVD  and
MI  was  slightly  lower  (Table  3).  The  other  risk  factors  were
qually  distributed.  The  association  between  CVD  and  CVD
isk  factors  is  presented  in  Table  4.  Hypertension  was  asso-
iated  with  a  3.69-fold  increased  risk  of  CVD.  Considering
he  different  localizations  of  CVD,  the  hypertension  hazard
atio  (HR)  was  2.03  (95%  CI  1.03—4.00;  P  <  0.05)  for  abnor-
al  tibial  posterior  pulse  palpation  (i.e.  PAD),  5.79  (95%  CI
.21—15.2;  P  <  0.05)  for  subclavian  stenosis  and  4.57  (95%
I  1.26—16.50;  P  <  0.05)  for  cerebrovascular  disease;  the
elationship  between  hypertension  and  a  positive  WHO  Rose
ngina  questionnaire  was  close  to  signiﬁcance  (HR  2.32,  95%
I  0.93—5.79).  Being  male  also  conferred  an  increased  risk
f  PAD  (HR  2.34,  95%  CI  1.13—4.83;  P  <  0.05).
80  E.B.  Ngoungou  et  al.
Table  1  General  characteristics  of  the  study  population.
Characteristic  Overall(n  =  736)  Men(n =  313)  Women(n  =  423)  P
Agea (years)  57.0  ±  11.6  57.2  ±  11.4  56.8  ±  11.8  0.64
Smoker  254  (34.5)  123  (39.3)  131  (31.0)  0.03
Dyslipidaemia  14  (1.9)  6  (1.9)  8  (1.9)  0.99
Diabetes 12  (1.6) 8  (2.6) 4  (1.0)  0.14
Hypertension 382  (51.9) 166  (53.0) 216  (51.1) 0.61
Treated  hypertension 74  (10.5) 27  (8.6) 47  (11.1) 0.32
Body  mass  index  (kg/m2)  28.1  ±  7.9  27.2  ±  6.6  28.7  ±  8.6  0.02
Data are mean ± standard deviation or number (%).
a Calculated for only 681 participants of known age.
Figure 1. Overall and known prevalences of hypertension (HTN) by sex and age.
Figure 2. Known and unknown cardiovascular disease (CVD) by sex and age in Ntoum, Gabon.
CVD  in  Gabon  
Table  2  Clinical  ﬁndings:  symptomatic  and  asymp-
tomatic  cardiovascular  disease.
Condition  Number  (%)
History  of  myocardial  infarction  16  (2.2)
History  of  stroke  16  (2.2)
Positive  WHO  Rose  angina  questionnaire 14 (1.9)
ECQ  —deﬁnite  0 (0)
ECQ  —possiblea 19 (2.7)
At  least  one  limb  with  absent  distal  pulses  25  (3.4)
Subclavian  stenosis  38  (5.1)
a Possible Edinburgh claudication questionnaire (ECQ) deﬁned
as exercise calf pain not present at rest but otherwise not
fully concordant with the ECQ criteria. WHO: World Health
Organization.
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Figure 3. Prevalences of coronary artery disease (CAD), cerebrovascul
stenosis (SS) by sex and age.
Table  3 Risk  factors  for  any  cardiovascular  disease:  univariat
Factor  Subjects  with  CVD(n =  98)  
Age  (years)  59.4  ±  12.8  
Male  45  (45.9)  
Smoker  38  (38.8)  
Treated  dyslipidaemia  3  (3.1)  
Treated  diabetes  2  (2.0)  
Hypertension  73  (74.5)  
Body  mass  index  (kg/m2)  27.2  ±  8.9  
Data are mean ± standard deviation or number (%). CVD: cardiovascula81
iscussion
n  this  survey,  we  documented  a  high  prevalence  of  CVD
n  the  Gabonese  community.  Over  the  age  of  40  years,
ore  than  13%  of  the  population  presented  symptomatic
r  asymptomatic  CVD.  In  previous  studies  [15—17], all  of
he  clinical  and  subclinical  conditions  detected  in  this  study
ere  associated  with  a  high  risk  of  cardiovascular  events
uring  follow-up.  Our  data  are  in  accordance  with  other
ata  supporting  an  epidemiological  transition  in  Africa,  with
levated  rates  of  chronic  conditions,  particularly  CVDs,  in
ub-Saharan  countries.  In  the  Southern  African  Stroke  Pre-
ention  Initiative  (SAPSI)  study,  Fowkes  et  al.  [18]  reported
 prevalence  of  PAD  deﬁned  by  a  low  ankle-brachial  index
<  0.9)  of  3.9%,  11%  and  25.5%  in  the  age  groups  of  40  to
9,  50  to  59  and  60  to  69  years,  respectively;  the  distribu-
ion  was  very  similar  to  that  found  in  western  populations.
t  is  important  to  notice  that  in  our  study,  11.5%  of  men  and
.9%  of  women  presented  an  unknown  CVD.  Data  screening
rogrammes  might  therefore  be  useful.
Given  the  paucity  of  healthcare  resources  in  develo-
ing  countries,  it  is  of  critical  concern  to  develop  simple,
ar disease (CBVD), peripheral arterial disease (PAD) and subclavian
e  analysis.
Subjects  withoutCVD  (n  =  583)  P
56.6  ±  11.3  0.03
257  (44.1)  0.75
196  (33.6)  0.49
10  (1.7)  0.41
10  (1.7)  0.69
277  (47.5)  <  0.0001
28.4  ±  7.6  0.17
r disease.
82  E.B.  Ngoungou  et  al.
Table  4  Risk  factors  for  any  cardiovascular  disease:  multivariable  analysis.
Factor  Initial  model  P  Final  P
Age 1.01  (0.98—1.03)  0.54
Male  1.05  (0.66—1.65)  0.82
Smoker  1.09  (0.67—1.77)  0.72
Treated  dyslipidaemia  1.98  (0.48—8.23)  0.35
Treated  diabetes 1.01  (0.19—5.30)  0.99
Hypertension 3.55 (2.11—5.97) <  0.0001  3.69 (2.21—6.16)  <  0.0001
Body  mass  index 0.97 (0.94—1.00) 0.06  0.97 (0.94—1.00) 0.049
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cData are hazard ratio (95% conﬁdence interval).
ow-cost  tools  for  detecting  subjects  at  high  risk  of  CVD
n  these  populations.  In  this  context,  screening  for  subcla-
ian  stenosis  could  be  a  useful  strategy.  The  prevalence  of
ubclavian  stenosis  was  5.1%  in  our  study.  Subclavian  steno-
is  deﬁned  similarly  to  this  study  (interarm  systolic  blood
ressure  difference  greater  than  15  mmHg)  was  found  in
.9%  of  a  community-dwelling  population  in  the  USA  and
n  7.1%  of  outpatients  visiting  a  vascular  laboratory  [19].
n  another  study  [20], the  traditional  CVD  risk  factors  were
losely  associated  with  subclavian  stenosis;  the  prevalence
as  1.7%  in  subjects  without  CVD  risk  factors  but  increased
o  4.3%  in  case  of  smoking  or  hypertension  and  6.8%  in
ase  of  diabetes.  The  predictive  value  of  subclavian  stenosis
as  documented  in  a  multicohort  study  that  included  1778
articipants  [15]; among  them,  8.8%  presented  an  subcla-
ian  stenosis  as  deﬁned  above.  During  a  mean  follow-up  of
.8  years,  this  condition  was  associated  with  an  increased
isk  of  CVD  (HR  1.57;  P  =  0.05)  and  total  mortality  (HR
.40;  P  <  0.01).  While  the  prognostic  value  of  subclavian
tenosis  in  African  people  has  not  yet  been  assessed,  it  is
lausible  that  subclavian  stenosis  could  be  helpful  for  the
linical  estimation  of  individual  cardiovascular  risk.  In  line
ith  this,  a  multiethnic  cohort  in  the  USA,  including  par-
icipants  of  African  descent,  found  a  positive  association
etween  subclavian  stenosis  and  coronary  artery  calcium
core  [21].
High  blood  pressure  was  highly  prevalent,  with  more  than
0%  of  these  semiurban  dwellers  presenting  with  systolic
lood  pressure  greater  than  160  mmHg.  Such  a  high  preva-
ence  of  hypertension  has  been  described  previously,  with
ifferences  between  rural  and  urban  communities;  the  lev-
ls  of  hypertension  were  15.4%  in  a  rural  community  in
ameroon,  50%  in  an  urban  community  in  Ghana  [9,22]  and
3%  in  a  community  in  South  Africa  [23]. In  our  study,  hyper-
ension  was  closely  related  to  an  increased  risk  of  CVD  and,
n  particular,  with  a  5.7-fold  increased  risk  of  subclavian
tenosis.  As  the  risk  of  CVD  is  related  to  blood  pressure,
his  situation  might  lead  to  an  increased  risk  of  stroke,
idney  disease  or  heart  failure.  In  addition,  in  the  INTER-
EART  study  [5],  the  risk  of  myocardial  infarction  related
o  hypertension  was  higher  in  the  black  African  group  than
n  the  overall  group.  The  situation  in  the  Gabonese  com-
unity  is  very  similar  to  that  described  by  Addo  et  al.  inub-Saharan  Africa  [24], who  reported  that  less  than  40%
f  hypertensive  subjects  were  detected,  less  than  30%  of
hose  diagnosed  with  hypertension  were  receiving  treat-
ent  and  less  than  20%  were  actually  controlled.  These  data
t
d
f
monﬁrm  the  urgent  need  for  preventive  strategies  in  these
ountries.
imitations
here  are  a  few  limitations  to  our  study.  First,  women  were
ver-represented,  so  sick  men  might  be  over-represented  as
 result  of  healthy  men  working  far  from  the  home.  However,
ver  the  age  of  65  years,  the  Gabonese  population  demon-
trates  a  female  predominance,  with  a  male:female  ratio  of
.72  [25]. Except  for  hypertension,  risk  factor  collection  was
eclarative,  so  we  probably  underestimated  the  real  burden
f  diabetes  and  dyslipidaemia.  All  the  data  were  conﬁrmed
ith  prescriptions,  health  records  and  hospital  chart  analy-
is.  The  response  rates  for  tobacco  smoking  were  low,  partly
xplained  by  the  different  types  of  smoking  (e.g.  pipe)  and
ess  smoking  of  manufactured  cigarettes.  In  the  Limpopo
tudy  [6],  women  used  mainly  smokeless  tobacco  (snuff  and
hewing);  we  did  not  document  this  sort  of  practice.  The
eﬁnition  of  high  blood  pressure  as  a systolic  measurement
reater  than  160  mmHg  may  overestimate  the  links  between
ypertension  and  CVD;  conversely,  the  relationship  might  be
nderestimated  for  other  risk  factors,  particularly  DM,  as
heir  deﬁnitions  were  declarative,  resulting  in  a  low  preva-
ence.  A  further  limitation  is  that  no  subject  described  a
ositive  ECQ,  even  with  a  validated  translated  version  of
he  questionnaire.  The  representation  of  pain  when  walking
ight  be  different  in  this  population.  The  Gabonese  popula-
ion  is  French  speaking  with  quite  a  good  educational  level:
reater  than  60%  of  the  population  aged  greater  or  equal
o  15  years  can  read  and  write  [25], and  the  questionnaires
ere  administered  by  local  investigators.  Yet  our  ﬁndings
hould  be  considered  as  conservative  and  it  is  possible  that
he  burden  of  CVD  in  this  sub-Saharan  country  is  underesti-
ated  in  our  study.  Further  surveys  studying  the  relationship
etween  subclinical  CVD  and  ultrasound  methods  in  African
ommunity  are  awaited.
onclusion
ur  ﬁndings  conﬁrm  the  high  prevalence  of  clinical  and  sub-
linical  CVD  in  a  sub-Saharan  community.  They  also  conﬁrm
he  increasing  burden  of  hypertension.  Taken  together,  these
ata  support  the  ongoing  epidemiological  transition.  In  the
uture,  cardiovascular  prevention  measures  should  be  imple-
ented  in  these  countries.
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